Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors “A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome”
Crossref DOI link: https://doi.org/10.1007/s00262-016-1845-2
Published Online: 2016-05-19
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Spain, Lavinia
Larkin, James
Martin-Liberal, Juan
Text and Data Mining valid from 2016-05-19